Anti-obesity drugs: to be or not to be?
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Works matching DE "UNITED States. Food %26 Drug Administration. Endocrinologic & Metabolic Drugs Advisory Committee"
Results: 4
1
2
FAT CHANCE: THE REVITALIZATION OF THE OBESITY DRUG PIPELINE.
- Published in:
- Syracuse Law Review, 2014, v. 64, n. 1, p. 49
- By:
- Publication type:
- Article
3
Panel advises against rimonabant approval.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 14, p. 1460, doi. 10.2146/news070065
- By:
- Publication type:
- Article
4
Assessing the Benefit-Risk for New Drugs.
- Published in:
- 2013
- By:
- Publication type:
- Opinion